If there are any members on this board who know of anybody in dire need of Reticulose, please communicate the follwing: Reticulose is available to those who need it and can afford it. And this is the way to get it:
A.V.R. CANADA INC.
Clinical Use of Reticulose- USA
A maximum of three months (90 days) supply of Reticulose ampules can be provided
under the FDA policy for - “importing unaproved drugs for personal use”. However,
please note that U.S. Custom officers require the following pieces of identification
before they will let a shipment of Reticulose into the U.S
A. The Patient’s SS number B. Photostat of the license or Passport I.D.
1. All requests should be forwarded to: A.V.R. Canada Inc., P.O. BOX 1585, Riguad,
Quebec, Canada, JOP 1PO. If you are using a courier insert, the civic address is
20 Roundtree Cr., Riguad, Quebec, Canada JOP 1PO.
2. All requests MUST include a personal letter from the patient stating that he/she
wants Reticulose treat this indication.
3. You also have to include a prescription or a signed letter from a licensed U.S.
physician. The letter should simply state that the doctor is prepared to follow the
progress of the patient requesting Reticulose. Most physicians issue a prescription
on a PRN basis, which is good for 12 months, should you be treating a chronic condition.
4. A signed and witnessed- Patient Consent Form- MUST also be enclosed.
5. All orders need to have a money order/certified check made out to - A..V.R. Canada
Inc. for the total amount.
6. PRICE: 10 to 25 ampules- $25/ampule
25 or more ampules- $20/ampule
7. A.V.R. Canada also requests that we be informed of the progress of the patient
while on Reticulose, together with any comments (Patient or Physician).
8. Shipments will normally be sent within 48 hours by FEDEX Economy Air. There is a
charge of $15.00 for this service.
9. Please note that when requesting repeat orders of Reticulose, you should include an additional letter with each request - FDA requirement.
-PATIENT CONSENT-
Patient declaration of independent and voluntary request for Compassionate
Treatment of :
________________________________
In his/her desire to voluntarily treat themselves with a product called RETICULOSE in
a setting of a medically confirmed indication of :
________________________________
The undersigned patient will hold harmless and blameless of any responsibility
of any kind or value, the manufacturer of the drug- Advanced Viral Research Corp., or
any his/her associates: whether legal, medical or social.
He/she holds them blameless of any morbidity or pathology, as well as any
emotional, psychological, or other real, perceived or imagined discomfort as a
consequence of his/her request for assistance in the patients desire to receive and
use Reticulose.
The patient understands that his/her meeting of all requirements of this are solely
his/her responsibility.
This document must be signed by the participant before two (2) witnesses and
submitted to: A.V.R. Canada Inc., P.O. Box 1585, Riguad, Quebec, Canada JPO 1PO
Patient’s name:________________________ S.S.N._________________
Patient’s signature: _____________________
Witness: _____________________________
Witness: _____________________________
Date: ________________________________
SUBJECT: Suggested letter for F.D.A. from physician
The F.D.A. today confirmed that they would accept a letter, along the lines below
as satisfactory approval for following a patient on Reticulose:
A.V.R. Canada Inc.
P.O.Box 1585
Riguad, Quebec, Canada JOP 1PO
“ This is to state That I, Dr. ________________, will follow Mr./Mrs.______________
who will be taking Reticulose for ____________________desease/ indication.”
signed
* ( Must be on the doctor’s letterhead with his address and telephone number
clearly shown.)
Such a note can beused in cases where a physician is reluctant to write a
prescription for an unapproved drug.
The following is from an FDA notice:
If a drug(s) is not approved for distribution in the United States, the FDA may
consider releasing the product either to you or your physician for your own personal
use if you provide a written statement containing the following information:
(1) adequate documentation that the product is for your use only and is for the
treatment of a serious condition;
(2) the shipment is not for resale or commercial distribution;
(3) the shipment is less than a 90 day supply; and
(4) include the name, address and telephone number of the physician licensed to practice in the United States who is responsible for your treatment with the product;
OR
Adequate documentation that the product is for the continuation of a treatment of a
serious condition begun in a foreign country, and the name, address and telephone
number of the licensed U.S. physician under whose care you will be while taking this
drug.
Anybody who is interested in using Reticulose may contact Mr. William Bregman at 954-458-7636 or send me an E-mail at NewConcepts@RagingBull.com and I will fax a formatted formletter ASOP. |
